Keyphrases
Epithelial Cells
100%
IL-4 Receptor
100%
Eosinophilic Esophagitis
100%
Interleukin-13 (IL-13)
45%
Interleukin-4 (IL-4)
27%
IL-4Rα
27%
Inflammation
9%
Relative Contribution
9%
Therapeutic Target
9%
Phenyl
9%
Mode of Action
9%
Overproduction
9%
Clinical Features
9%
Current Therapies
9%
Cell Proliferation
9%
RNA-seq Data
9%
Eosinophilia
9%
Mechanistic Insight
9%
Th2 Cytokines
9%
Clinical Efficacy
9%
Antibody-drug Conjugate
9%
Antibody-based
9%
Future Therapeutics
9%
Basal Cell
9%
Transcriptome Analysis
9%
Targeted Deletion
9%
Histopathological Features
9%
Tissue Remodeling
9%
Lamina Propria
9%
Human Antibody
9%
Eosinophils
9%
Allergic Diseases
9%
Signature Genes
9%
Esophagus
9%
Esophageal Cancer Cells
9%
Esophageal Epithelium
9%
Dupilumab
9%
Single-cell RNA Sequencing Analysis
9%
Medicine and Dentistry
Epithelial Cell
100%
Receptor
100%
Eosinophilic Esophagitis
100%
Interleukin 13
45%
Disease
9%
Biopsy
9%
Clinical Feature
9%
Cell Proliferation
9%
Gene Expression Profiling
9%
Cytokine
9%
Histopathology
9%
Basal Cell
9%
Lamina Propria
9%
Eosinophil
9%
Eosinophilia
9%
RNA Sequence
9%
Neutralization
9%
Esophagus
9%
Drug Antibody
9%
Dupilumab
9%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Eosinophilic Esophagitis
100%
Interleukin 13
45%
Mouse
27%
Inflammation
9%
Disease
9%
Clinical Feature
9%
Cytokine
9%
RNA-Sequencing
9%
Transcriptome
9%
Eosinophilia
9%
Drug Antibody
9%
Dupilumab
9%
Immunology and Microbiology
Esophagitis
100%
Interleukin 13
45%
Mouse
27%
Cell Proliferation
9%
Cytokine
9%
Gene Expression Profiling
9%
Neutralization
9%
Drug Antibody
9%
Basal Cell
9%
RNA Sequence
9%
Eosinophil
9%
Lamina Propria
9%
Esophagus
9%
Dupilumab
9%